Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Thomas J. Schnitzer, MD, PhD
May 31, 2018
Latest press releases
2025-05-14 07:30
Infant Bacterial Therapeutics (IBT) to present results of “The Connection Study” at ESPGHAN 2025 in Helsinki
2025-05-08 17:45
Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2025-05-08 07:00
IBT Submits Clinical Study Report for ‘The Connection Study’ to the FDA
2025-05-07 14:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – March 31, 2025
Regulatory
2025-04-24 07:20
Infant Bacterial Therapeutics (IBT) to Present Results of “The Connection Study” at PAS 2025 in Honolulu
